Many pvt colleges opt for no fee hike, relief for aspirants
Tired of too many ads? go ad free now
Among the colleges charging fees over Rs 10 lakh are two offering the sought-after MBBS programmes and five offering MD/MS courses. Among the engineering colleges, Bhavan's Sardar Patel Institute of Technology and Thakur College are also not seeking any upward revision in their fee review proposals to the state's Fee Regulating Authority (FRA). So far, 115 colleges offering pharmacy have sought no fee hike, along with 100 MBA colleges, 75 engineering ones, and 16 ayurveda colleges, among others.
Amravati's Dr Punjabrao Deshmukh Memorial Medical College, which charged Rs 10.8 lakh last year for MBBS and Rs 12.3 lakh for MD/MS, will continue with the same amount this year. Talegaon's MIMER Medical College's MBBS fees will also remain constant at Rs 11.3 lakh. For postgraduate MD/MS courses, Mumbai's Bombay Hospital Institute of Medical Sciences (Rs 10 lakh), ACPM Medical College, Dhule (Rs 10.74 lakh), Sanjeevan Medical College, Miraj (Rs 9.6 lakh), and Warudi's JIIU's Indian Institute of Medical Science and Research (Rs 9 lakh) will maintain the same fees as last year.
No fee hike is always good news for students, but many private medical colleges are overcharging students in the name of security deposits, hostel fees, and club charges, said parent representative Sudha Shenoy.
One of the PG medical colleges saw the fee double last year, and many of these private colleges do not even pay stipends at par with govt colleges, said Shenoy.
The FRA, last year, decided to cap the caution money at Rs 50,000 for all medical courses and fixed upper limits for other courses too.
Tired of too many ads? go ad free now
FRA chairperson and former Bombay HC judge Vijay Lakhichand Achliya said that many of these colleges may be satisfied with the fees they charged in the previous year. Another official mentioned that some colleges in rural areas may not be hiking their fees as they may not attract students for higher fees. A principal from an engineering college said that some colleges assess their expenditure and, realising that the fees may drop during the review process, do not seek any upward revision.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
an hour ago
- Time of India
Delhi Half Marathon enters 20th year with report on its impact
New Delhi: Vedanta Delhi Half Marathon (VDHM) has flagged off its 20th edition with the release of a first-of-its-kind Socio-Economic and Health Impact Report, reflecting the event's enduring impact on public health, fitness and civic engagement. Tired of too many ads? go ad free now The online registration for VDHM 2025 opened on Thursday and the event is scheduled to take place on Oct 12. The launch of the report, compiled by Miranda House of Delhi University, was attended on Wednesday by tourism and law and justice minister Kapil Mishra, sports and education minister Ashish Sood, New Delhi Municipal Council secretary Tariq Thomas, former hockey player PR Sreejesh and Miranda principal Bijaylaxmi Nanda, among others. "Delhi govt and Delhi Tourism will support Vedanta Delhi Half Marathon. We will be part of it this year and in the coming years. The Prime Minister's vision for Delhi includes economy, sports and fitness, and under chief minister Rekha Gupta's guidance, we are ready to implement it," said Mishra. Sood reflected on India's cultural foundations in fitness. "Sports and activities are promoted in our villages, from akhadas to morning walks in the park—fitness has not only created healthy bodies but also healthy relationships and a healthy society. In today's modern era, this community feeling is exemplified by Vedanta Delhi Half Marathon." Highlighting the cause behind the event, Priya Agarwal Hebbar, non-executive director of Vedanta Ltd, noted, "Over the last three editions, every step taken has helped nourish a child or feed an animal. I'm proud to share that we've enabled over 17 million meals through #RunForZeroHunger, and this year, we're pushing this milestone even further. Tired of too many ads? go ad free now As Vedanta Delhi Half Marathon turns 20 this year, we reaffirm our commitment to the cause of nourishing India through collective actions. " Expressing her institution's pride in conducting the study, Nanda said, "We are delighted to be part of this initiative by Procam International to release this first-ever comprehensive study on the multifold and lasting impact of Vedanta Delhi Half Marathon." Calling the 20th edition more than a milestone, Anil Singh, MD of Procam International, said, "It's a celebration of a legacy built step by step, year after year. What started as a vision to create a world-class sporting event in India has grown into a symbol of resilience, community and hope." According to the report, the 2024 edition generated an estimated Rs 368.86 crore in combined socio-economic and health benefits. Major contributors included Rs 198.96 crore through consumer spending on fitness gear and technology and Rs 155.25 crore through boosts to the food, travel, hospitality and training sectors. The event also led to employment worth Rs 11.38 crore and helped raise Rs 3.27 crore for charity. This year, Lakshyaa Foundation is joining as the official philanthropy partner while Samarthanam Trust for the Disabled will serve as the Champions with Disability facilitator, bridging the gap between stakeholders and differently abled participants. The registration will stay open till Sept 19 or until the slots are filled. The categories include Half Marathon, Open 10K, Great Delhi Run, Senior Citizens' Run and Champions with Disability. A Virtual Run option will again allow global participation via the official app.
&w=3840&q=100)
Business Standard
2 hours ago
- Business Standard
Corona Remedies acquires 7 pharma brands from Bayer India, plans expansion
Ahmedabad-based Corona Remedies on Thursday announced an expansion of its pharmaceutical portfolio, acquiring seven brands from the pharmaceutical division of Bayer in India, effective from 16 July. This move marks Corona Remedies' fourth acquisition from a multinational corporation. The company did not disclose the value of the deal. The acquisition includes Noklot in the cardiology segment and six women's healthcare brands — Fostine, Luprofact, Menodac, Ovidac, Spye and Vageston. This portfolio expansion marks Corona's entry into the Rs 1,507-crore anti-platelet monotherapy market, which is growing at 8 per cent annually, and deepens its footprint in the Rs 1,862-crore gonadotrophin and progesterone hormone segment, used primarily in infertility treatment and pregnancy management. When contacted for financial details of the deal, the company stated that it was unable to disclose them at this time as it has filed for an initial public offering (IPO). The company plans to integrate the newly acquired brands into its existing operations and leverage its extensive sales and distribution network to ensure wider reach across metro, semi-metro, urban and rural regions. Corona Remedies said the brands are expected to deliver growth under its stewardship. GCV Life served as the advisor for the transaction. Founded in 2004, Corona Remedies is a branded pharmaceutical company focused on therapeutic areas such as women's healthcare, cardio-diabetes, urology and pain management. The company employs over 4,000 people and operates two Department of Scientific and Industrial Research (DSIR)-approved research and development centres.
Time of India
9 hours ago
- Time of India
Mukul Agrawal picks 1.14% stake in smallcap stock in Q1FY26
Ace investor Mukul Mahavir Agrawal picked up a 1.14% stake in small-cap Yatharth Hospital & Trauma Care Services during the June 2025 quarter, as per the latest shareholding data. Agrawal acquired 11,00,000 shares, valued at approximately Rs 68.1 crore based on the current market price of Rs 618.2. Explore courses from Top Institutes in Select a Course Category CXO MBA Project Management Others Data Science Design Thinking Leadership Healthcare Digital Marketing Artificial Intelligence Product Management Public Policy Data Science Finance healthcare MCA Degree PGDM Cybersecurity Technology Management Data Analytics Skills you'll gain: Digital Strategy Development Expertise Emerging Technologies & Digital Trends Data-driven Decision Making Leadership in the Digital Age Duration: 40 Weeks Indian School of Business ISB Chief Digital Officer Starts on Jun 30, 2024 Get Details Skills you'll gain: Operations Strategy for Business Excellence Organizational Transformation Corporate Communication & Crisis Management Capstone Project Presentation Duration: 11 Months IIM Lucknow Chief Operations Officer Programme Starts on Jun 30, 2024 Get Details Skills you'll gain: Technology Strategy & Innovation Emerging Technologies & Digital Transformation Leadership in Technology Management Cybersecurity & Risk Management Duration: 24 Weeks Indian School of Business ISB Chief Technology Officer Starts on Jun 28, 2024 Get Details Skills you'll gain: Customer-Centricity & Brand Strategy Product Marketing, Distribution, & Analytics Digital Strategies & Innovation Skills Leadership Insights & AI Integration Expertise Duration: 10 Months IIM Kozhikode IIMK Chief Marketing and Growth Officer Starts on Apr 7, 2024 Get Details In today's trade, Yatharth Hospital shares surged 3% on BSE. The stock has gained 40% over the past six months. Also Read: 9 undervalued mid-cap stocks with upside potential of up to 23% In the same quarter, he also increased his stake in small-cap multibagger Prakash Industries by 0.3%, taking his total holding to 1.72% or 30,27,554 shares. Live Events Meanwhile, earlier, Agrawal also trimmed his holdings in two small-cap stocks — Sula Vineyards and Raghav Productivity Enhancers — during the quarter ended June 30, 2025. His stake in Sula Vineyards fell by 41 basis points (bps) over the March quarter, bringing his current holding to 1.78%. In Raghav Productivity, the stake was reduced by 51 bps to 1.04%, according to BSE data. The reduction in Sula Vineyards comes amid sustained underperformance, with the stock losing 40% over the past year and 28% in 2025 so far. In contrast, Raghav Productivity had rallied 56% in the last 12 months, outperforming the Nifty's 2% gain during the same period. The recent trimming appears to be profit-booking, especially as the stock has declined over 5% in 2025, while the Nifty has gained more than 5%. Mukul Agrawal Portfolio Agrawal, known for identifying multibaggers, publicly holds 61 stocks with a combined net worth of over Rs 6,870 crore as of the June quarter. His top holdings include Neuland Laboratories, BSE, Radico Khaitan, Nuvama Wealth, Deepak Fertilisers, Intellect Design, and PTC Industries. In the June quarter, Agrawal also added SME stock Monolithisch India to his portfolio, purchasing 5 lakh shares or a 2.30% stake. Additionally, he acquired a 1.27% stake in Jammu & Kashmir Bank. Also Read: SBI, Federal Bank among 11 banks that saw NPA improvement in Q4 ( Disclaimer : Recommendations, suggestions, views, and opinions given by the experts are their own. These do not represent the views of The Economic Times)
